Literature DB >> 8265582

Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II.

M Kretzschmar1, M Meisterernst, R G Roeder.   

Abstract

The transcriptional activation of eukaryotic class II genes by sequence-specific regulatory proteins requires cofactors in addition to the general transcription factors. One cofactor (termed PC3) was purified from HeLa cells and identified by sequence analysis and functional assays as human DNA topoisomerase I (EC5.99.1.2). Under identical conditions PC3 mediates both a net activation of transcription by the acidic activator GAL4-AH and repression of basal transcription, thereby leading to a large induction of transcription by the activator. PC3-mediated activation of transcription is dependent on the presence of both the GAL4-AH activation domain and the TATA-binding protein (TBP)-associated-factors (TAFs) in natural transcription factor TFIID, while repression of basal transcription is observed with either TFIID or the derived TBP alone. These results suggest novel functions, apparently through distinct mechanisms, for human DNA topoisomerase I in the regulation of transcription initiation by RNA polymerase II.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265582      PMCID: PMC48013          DOI: 10.1073/pnas.90.24.11508

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts.

Authors:  B C Giovanella; J S Stehlin; M E Wall; M C Wani; A W Nicholas; L F Liu; R Silber; M Potmesil
Journal:  Science       Date:  1989-11-24       Impact factor: 47.728

Review 2.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

3.  Transcription factor TFIID induces DNA bending upon binding to the TATA element.

Authors:  M Horikoshi; C Bertuccioli; R Takada; J Wang; T Yamamoto; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

Review 4.  Diverse transcriptional functions of the multisubunit eukaryotic TFIID complex.

Authors:  B F Pugh; R Tjian
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

5.  Activation of class II gene transcription by regulatory factors is potentiated by a novel activity.

Authors:  M Meisterernst; A L Roy; H M Lieu; R G Roeder
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

6.  Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies.

Authors:  A Hoffmann; R G Roeder
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

Review 7.  The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly.

Authors:  R G Roeder
Journal:  Trends Biochem Sci       Date:  1991-11       Impact factor: 13.807

8.  Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities.

Authors:  A F Stewart; R E Herrera; A Nordheim
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

9.  Co-crystal structure of TBP recognizing the minor groove of a TATA element.

Authors:  J L Kim; D B Nikolov; S K Burley
Journal:  Nature       Date:  1993-10-07       Impact factor: 49.962

10.  Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II.

Authors:  M Potmesil; Y H Hsiang; L F Liu; B Bank; H Grossberg; S Kirschenbaum; T J Forlenza; A Penziner; D Kanganis; T J Forlenzar
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

View more
  64 in total

1.  The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.

Authors:  C Gobert; A Skladanowski; A K Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter.

Authors:  T C Kuhlman; H Cho; D Reinberg; N Hernandez
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status.

Authors:  Yinghui Mao; Issac R Mehl; Mark T Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Disconnecting XRCC1 and DNA ligase III.

Authors:  Sachin Katyal; Peter J McKinnon
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

5.  Potential protein partners for the N-terminal domain of human topoisomerase I revealed by phage display.

Authors:  Agata M Trzcińska; Agnieszka Girstun; Agnieszka Piekiełko; Barbara Kowalska-Loth; Krzysztof Staroń
Journal:  Mol Biol Rep       Date:  2002-12       Impact factor: 2.316

6.  Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.

Authors:  Neelima Mondal; Ye Zhang; Zophonias Jonsson; Suman Kumar Dhar; Madhu Kannapiran; Jeffrey D Parvin
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

7.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.

Authors:  Stéphanie Solier; Jennifer Barb; Barry R Zeeberg; Sudhir Varma; Mike C Ryan; Kurt W Kohn; John N Weinstein; Peter J Munson; Yves Pommier
Journal:  Cancer Res       Date:  2010-09-03       Impact factor: 12.701

8.  Separation of the transcriptional coactivator and antirepression functions of transcription factor IIA.

Authors:  D MA; I Olave; A Merino; D Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

9.  Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera.

Authors:  M Satoh; A K Ajmani; T Ogasawara; J J Langdon; M Hirakata; J Wang; W H Reeves
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation.

Authors:  T K Kim; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.